An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen

被引:53
作者
Bonnet, B. [1 ,2 ]
Messaoudi, K. [3 ]
Jacomet, F. [4 ]
Michaud, E. [5 ]
Fauquert, J. L. [5 ]
Caillaud, D. [6 ]
Evrard, B. [1 ,2 ]
机构
[1] Univ Clermont Auvergne, Unit Nutr Humaine, Lab Immunol, ECREIN,UMR1019, F-63000 Clermont Ferrand, France
[2] CHU Clermont Ferrand, Serv Immunol, F-63000 Clermont Ferrand, France
[3] CHU Angers, Lab Biochim, Angers, France
[4] CHU Poitiers, Lab Immunol, Poitiers, France
[5] CHU Clermont Ferrand, Serv Pediat, F-63000 Clermont Ferrand, France
[6] CHU Clermont Ferrand, Serv Pneumol, F-63000 Clermont Ferrand, France
来源
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY | 2018年 / 14卷
关键词
Cat allergy; Fel d 1; CRD; Immunotherapy; CARBOHYDRATE-BASED PARTICLES; D-I ALLERGEN; INTRALYMPHATIC IMMUNOTHERAPY; COMPONENT SENSITIZATION; INHALANT ALLERGENS; FURRY ANIMALS; IGE ANTIBODY; DOG ALLERGEN; US HOMES; ASTHMA;
D O I
10.1186/s13223-018-0239-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Cats are the major source of indoor inhalant allergens after house dust mites. The global incidence of cat allergies is rising sharply, posing a major public health problem. Ten cat allergens have been identified. The major allergen responsible for symptoms is Fel d 1, a secretoglobin and not a lipocalin, making the cat a special case among mammals. Main body: Given its clinical predominance, it is essential to have a good knowledge of this allergenic fraction, including its basic structure, to understand the new exciting diagnostic and therapeutic applications currently in development. The recent arrival of the component-resolved diagnosis, which uses molecular allergens, represents a unique opportunity to improve our understanding of the disease. Recombinant Fel d 1 is now available for in vitro diagnosis by the anti-Fel d 1 specific IgE assay. The first part of the review will seek to describe the recent advances related to Fel d 1 in terms of positive diagnosis and assessment of disease severity. In daily practice, anti-Fel d 1 IgE tend to replace those directed against the overall extract but is this attitude justified? We will look at the most recent arguments to try to answer this question. In parallel, a second revolution is taking place thanks to molecular engineering, which has allowed the development of various forms of recombinant Fel d 1 and which seeks to modify the immunomodulatory properties of the molecule and thus the clinical history of the disease via various modalities of anti-Fel d 1-specific immunotherapy. We will endeavor to give a clear and practical overview of all these trends.
引用
收藏
页数:9
相关论文
共 89 条
  • [1] Sublingual immunotherapy with a standardized cat dander extract:: evaluation of efficacy in a double blind placebo controlled study
    Alvarez-Cuesta, E.
    Berges-Gimeno, P.
    Mancebo, E. G.
    Fernandez-Caldas, E.
    Cuesta-Herranz, J.
    Casanovas, M.
    [J]. ALLERGY, 2007, 62 (07) : 810 - 817
  • [2] ANDERSON MC, 1981, J IMMUNOL, V127, P972
  • [3] Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: Results from the National Survey of Lead and Allergens in Housing
    Arbes, SJ
    Cohn, RD
    Yin, M
    Muilenberg, ML
    Friedman, W
    Zeldin, DC
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) : 111 - 117
  • [4] Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: ABAMSE/MeDALL study
    Asarnoj, Anna
    Hamsten, Carl
    Waden, Konrad
    Lupinek, Christian
    Andersson, Niklas
    Kull, Inger
    Curin, Mirela
    Anto, Josep
    Bousquet, Jean
    Valenta, Rudolf
    Wickman, Magnus
    van Hage, Marianne
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (03) : 813 - +
  • [5] Evaluation of different techniques for washing cats: Quantitation of allergen removed from the cat and the effect on airborne Fel d 1
    Avner, DB
    Perzanowski, MS
    PlattsMills, TAE
    Woodfolk, JA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (03) : 307 - 312
  • [6] WHERE DOES CAT ALLERGEN-1 COME FROM
    BARTHOLOME, K
    KISSLER, W
    BAER, H
    KOPIETZSCHULTE, E
    WAHN, U
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 76 (03) : 503 - 506
  • [7] A population-based study of animal component sensitization, asthma, and rhinitis in schoolchildren
    Bjerg, Anders
    Winberg, Anna
    Berthold, Malin
    Mattsson, Lars
    Borres, Magnus P.
    Ronmark, Eva
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2015, 26 (06) : 557 - 563
  • [8] NATIVE AND RECOMBINANT FEL-DI AS PROBES INTO THE RELATIONSHIP OF ALLERGEN STRUCTURE TO HUMAN IGE IMMUNOREACTIVITY
    BOND, JF
    BRAUER, AW
    SEGAL, DB
    NAULT, AK
    ROGERS, BL
    KUO, MC
    [J]. MOLECULAR IMMUNOLOGY, 1993, 30 (16) : 1529 - 1541
  • [9] Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression
    Campbell, John D.
    Buckland, Karen F.
    McMillan, Sarah J.
    Kearley, Jennifer
    Oldfield, William L. G.
    Stern, Lawrence J.
    Gronlund, Hans
    van Hage, Marianne
    Reynolds, Catherine J.
    Boyton, Rosemary J.
    Cobbold, Stephen P.
    Kay, A. Barry
    Altmann, Daniel M.
    Lloyd, Clare M.
    Larche, Mark
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (07) : 1535 - 1547
  • [10] Sublingual immunotherapy: World Allergy Organization position paper 2013 update
    Canonica, Giorgio Walter
    Cox, Linda
    Pawankar, Ruby
    Baena-Cagnani, Carlos E.
    Blaiss, Michael
    Bonini, Sergio
    Bousquet, Jean
    Calderon, Moises
    Compalati, Enrico
    Durham, Stephen R.
    van Wijk, Roy Gerth
    Larenas-Linnemann, Desiree
    Nelson, Harold
    Passalacqua, Giovanni
    Pfaar, Oliver
    Rosario, Nelson
    Ryan, Dermot
    Rosenwasser, Lanny
    Schmid-Grendelmeier, Peter
    Senna, Gianenrico
    Valovirta, Erkka
    Van Bever, Hugo
    Vichyanond, Pakit
    Wahn, Ulrich
    Yusuf, Osman
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2014, 7